Testicular dysfunction in untreated Hodgkin's disease.

Area of Science:

• Endocrinology
• Oncology
• Reproductive Medicine

Background:

• Hodgkin's disease (HD) can affect gonadal function, but the underlying mechanisms of pretreatment hypogonadism are not fully understood.
• Previous studies suggest potential testicular damage, but the specific nature and origin of this dysfunction require further investigation.

Purpose of the Study:

• To investigate gonadal function in young men with Hodgkin's disease prior to therapy.
• To compare hormonal profiles and sperm parameters in HD patients with those in men with other malignancies, primary testicular failure, and normal controls.
• To elucidate the potential causes of pretreatment hypogonadism in Hodgkin's disease.

Main Methods:

• Assessed serum levels of testosterone (total and free), luteinizing hormone (LH), follicle-stimulating hormone (FSH), and prolactin in 19 men with HD before treatment.
• Compared these levels with those in 11 men with other malignancies, 13 men with primary testicular failure, and 19 normal men.
• Evaluated the acute testosterone response to human chorionic gonadotropin (HCG) administration.
• Assessed total sperm count and motility.

Main Results:

• Men with HD exhibited decreased total and free testosterone levels compared to normal controls.
• Testosterone levels in advanced/symptomatic HD were similar to primary testicular failure, but LH levels were normal.
• The testosterone response to HCG was greater in HD than in primary testicular failure.
• Basal FSH levels were lower than normal in HD patients.
• Total sperm count was reduced in 40% of HD patients, suggesting seminiferous tubular dysfunction specific to HD.
• Abnormal sperm motility was common in both HD and other malignancies, indicating a non-specific cancer effect.
• Serum prolactin levels were elevated in HD patients but not in other malignancies.

Conclusions:

• Pretreatment hypogonadism in Hodgkin's disease is complex and not solely due to primary testicular failure.
• Findings suggest a combination of pituitary and gonadal abnormalities contributing to testicular dysfunction in HD.
• Specific seminiferous tubular dysfunction is indicated in HD, while impaired sperm motility appears to be a general effect of malignancy.